Artemisinin‐based combination therapy for treating uncomplicated Plasmodium vivax malaria
N Gogtay, S Kannan, UM Thatte… - Cochrane Database …, 2013 - cochranelibrary.com
Background Plasmodium vivax is an important cause of malaria in many parts of Asia and
South America, and parasite resistance to the standard treatment (chloroquine) is now high …
South America, and parasite resistance to the standard treatment (chloroquine) is now high …
[HTML][HTML] Artemisinin‐based combination therapy for treating uncomplicated Plasmodium vivax malaria
N Gogtay, S Kannan, UM Thatte… - The Cochrane …, 2013 - ncbi.nlm.nih.gov
Background Plasmodium vivax is an important cause of malaria in many parts of Asia and
South America, and parasite resistance to the standard treatment (chloroquine) is now high …
South America, and parasite resistance to the standard treatment (chloroquine) is now high …
[PDF][PDF] Artemisinin-based combination therapy for treating un-complicated Plasmodium vivax malaria
N Gogtay, S Kannan, UM Thatte… - status and date: New …, 2013 - researchgate.net
Background Plasmodium vivax is an important cause of malaria in many parts of Asia and
South America, and parasite resistance to the standard treatment (chloroquine) is now high …
South America, and parasite resistance to the standard treatment (chloroquine) is now high …
[PDF][PDF] Artemisinin-based combination therapy for treating un-complicated Plasmodium vivax malaria
N Gogtay, S Kannan, UM Thatte, PL Olliaro… - status and date: New …, 2013 - core.ac.uk
Background Plasmodium vivax is an important cause of malaria in many parts of Asia and
South America, and parasite resistance to the standard treatment (chloroquine) is now high …
South America, and parasite resistance to the standard treatment (chloroquine) is now high …
Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria
N Gogtay, S Kannan, UM Thatte… - The Cochrane …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Plasmodium vivax is an important cause of malaria in many parts of Asia and
South America, and parasite resistance to the standard treatment (chloroquine) is now high …
South America, and parasite resistance to the standard treatment (chloroquine) is now high …
Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria
N Gogtay, S Kannan, UM Thatte… - Cochrane Database …, 2013 - archive.lstmed.ac.uk
Background Plasmodium vivax is an important cause of malaria in many parts of Asia and
South America, and parasite resistance to the standard treatment (chloroquine) is now high …
South America, and parasite resistance to the standard treatment (chloroquine) is now high …
[引用][C] Artemisinin‐based combination therapy for treating uncomplicated Plasmodium vivax malaria
N Gogtay, S Kannan, UM Thatte… - Cochrane Database …, 1996 - cochranelibrary.com
Background Plasmodium vivax is an important cause of malaria in many parts of Asia and
South America, and parasite resistance to the standard treatment (chloroquine) is now high …
South America, and parasite resistance to the standard treatment (chloroquine) is now high …
Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
N Gogtay, S Kannan, UM Thatte, PL Olliaro… - … Cochrane Database of …, 2013 - europepmc.org
Background Plasmodium vivax is an important cause of malaria in many parts of Asia and
South America, and parasite resistance to the standard treatment (chloroquine) is now high …
South America, and parasite resistance to the standard treatment (chloroquine) is now high …
Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
N Gogtay, S Kannan, UM Thatte, PL Olliaro… - … Cochrane Database of …, 2013 - europepmc.org
Background Plasmodium vivax is an important cause of malaria in many parts of Asia and
South America, and parasite resistance to the standard treatment (chloroquine) is now high …
South America, and parasite resistance to the standard treatment (chloroquine) is now high …
[PDF][PDF] Artemisinin-based combination therapy for treating un-complicated Plasmodium vivax malaria
N Gogtay, S Kannan, UM Thatte… - status and date: New …, 2013 - researchgate.net
Background Plasmodium vivax is an important cause of malaria in many parts of Asia and
South America, and parasite resistance to the standard treatment (chloroquine) is now high …
South America, and parasite resistance to the standard treatment (chloroquine) is now high …